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The use of ultrafiltration for inflammatory mediators removal during cardiopulmonary bypass in
coronary artery bypass graf surgery
Ultrafiltração para remover mediadores
inflamatórios durante circulação extracorpórea na
revascularização do miocárdio
Resumo
Objetivo: Investigar a eficácia da ultrafiltração na
remoção de mediadores inflamatórios liberados pela
circulação extracorpórea e correlacionar ultrafiltração com
alterações da função orgânica de acordo com o “Sequencial
Organ Failure Assessment Score”.
Métodos: Quarenta pacientes foram incluídos e
randomizados em dois grupos: “sem ultrafiltração” (n=20;
Grupo I) e “ultrafiltração” (n=20; Grupo II). Complementos
3 e 4 ativados, interleucina 1beta, 6, 8 e fator de necrose
tumoral alfa foram dosados antes da indução anestésica (T1),
5 minutos antes da circulação extracorpórea (T2), no líquido
ultrafiltrado (T3), 30 minutos (T4), 6 (T5), 12 (T6), 24 (T7),
36 (T8) e 48 (T9) horas após término da circulação
extracorpórea. “Sequencial Organ Failure Assessment Score”
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foi avaliado nos tempos 1, 6 e 9. Significância estatística foi
estabelecida com p ≤ 0,05.
Resultados: No líquido ultrafiltrado, apenas níveis de
fator de necrose tumoral alfa foram detectados. Níveis de
complemento 3 ativado, nos tempos 5 e 7, e complemento 4
ativado, nos tempos 5 e 6, foram significativamente elevados
no grupo sem ultrafiltração, e níveis de interleucina 6 foram
elevados no grupo ultrafiltrado, nos tempos 7 e 8.
Interleucina 1beta, 8, fator de necrose tumoral alfa, e
“Sequencial Organ Failure Assessment Score” não tiveram
diferenças significantes entre os grupos.
Conclusões: Ultrafiltração filtra significativamente fator
de necrose tumoral alfa, mas isto não influencia nos níveis
séricos desta citocina. Ultrafiltração com o tipo de filtro
usado neste estudo não tem efeito na disfunção orgânica e
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deverá ser usada apenas para controle volêmico nos pacientes
submetidos à circulação extracorpórea.
Descritores: Circulação extracorpórea. Ultrafiltração.
Citocinas. Falência de múltiplos órgãos/etiologia.
Abstract
Objective: To investigate the effectiveness of
ultrafiltration in removing inflammatory mediators released
by cardiopulmonary bypass and to correlate ultrafiltration
with alterations in organic function according to the
Sequential Organ Failure Assessment Score.
Methods: Forty patients were included and randomized
into two groups: “no ultrafiltration” (n=20; Group I) and
“ultrafiltration” (n=20; Group II). Activated complement 3
and 4, interleukins 1beta, 6, 8 and tumor necrosis factor
alfa were measured prior to anesthesia induction (Time 1),
5 minutes before cardiopulmonary bypass (Time 2), in the
ultrafiltrated fluid (Time 3), 30 minutes (Time 4), and 6
(Time 5), 12 (Time 6), 24 (Time 7), 36 (Time 8) and 48 (Time
9) hours following cardiopulmonary bypass. Sequential
Organ Failure Assessment Score was evaluated at Time 1, 6
and 9. Statistical significance was established at p ≤
 
0.05.
Results: In the ultrafiltrated fluid, only tumor necrosis
factor alfa levels were detected. Levels of activated
complement 3 at Times 5 and 7 and activated complement 4
at Times 5 and 6 were significantly higher in the unfiltered
Group, and levels of interleukin 6 were higher in the filtered
Group at Times 7 and 8. Interleukins 1beta, 8, tumor necrosis
factor alfa, and the Sequential Organ Failure Assessment
score were not significantly different between the groups.
Conclusions: Ultrafiltration significantly filtered tumor
necrosis factor alfa but did not influences serum levels of
this cytokine. Ultrafiltration with the type of filter used in
this study had no effect in organic dysfunction and should
be used only for volemic control in patients undergo
cardiopulmonary bypass.
Descriptors: Extracorporeal circulation. Ultrafiltration.
Cytokines. Multiple organ failure/etiology.
INTRODUCTION
Patients who undergo cardiac surgery with the use of
extracorporeal circulation (ECC) suffer a systemic
inflammatory reaction, previously referred to as post-
perfusion syndrome [1], and now called systemic
inflammatory response syndrome (SIRS). The most common
causes of SIRS include: surgical trauma, contact of the
blood with non-endothelial surfaces, cardiac reperfusion
and lung injury from ventilation during anesthesia. These
causes activate of a variety of biological systems, such as
the complement cascade, coagulation, fibrinolysis, and the
cellular and humoral immune system. Clinically, this post-
ECC SIRS affects pulmonary, renal, cerebral and cardiac
functions. SIRS manifests with fever, tachycardia, arterial
hypotension, leukocytosis, coagulopathy, susceptibility to
infections, and changes in vascular permeability leading to
the accumulation of interstitial fluid, vasoconstriction and
hemolysis [2]. In addition, 1-2% of all cases are linked to
multiple organ dysfunction syndrome [3].
Tumor necrosis factor-alpha (TNF-á), interleukin-1â (IL-
1â), interleukin 6 (IL-6) and interleukin 8 (IL-8) are the
cytokines most involved in post-ECC SIRS. These
cytokines are released by activation of the complement
system following contact of the blood with the artificial
surface of the extracorporeal circuit or through the action
of endotoxins. The cytokine release causes significant
pathophysiological changes in the organism [4,5].
Ultrafiltration in ECC has been proposed as a means of
removing inflammatory mediators.
METHODS
A prospective, randomized, observational study was
carried out in 40 patients who had cardiac artery bypass
graft (CABG) surgery, They were assigned to one of two
groups according to an alternating designation: no
ultrafiltration (n=20) or ultrafiltration (n=20) during ECC
(Table 1). The protocol was approved by the Internal
Review Board of the institution and each patient gave his/
her signed informed consent prior to admission.
Table 1. Clinical characteristics of the 40 patients who underwent
cardiac artery bypass graft (CABG) surgery.
M = male; F = female; ns = not statistically significant; Group I -
no ultrafiltration, Group II - with ultrafiltration
Characteristics
Gender
Age (years)
Body surface area(m²)
EuroSCORE logistic(%)
Duration of
ECC (minutes)
Duration of aortic
clipping (minutes)
Duration of myocardial
ischemia (minutes)
Number of grafts
Group I
16 M; 4 F
59.85 ± 9.9
1.77 ± 0.24 m²
2.16 ± 1.56 %
74.85 ± 17.6
49 ± 11.6
22.35 ± 9.4
2.9 ± 1.0
Group II
15 M; 5 F
59.25 ± 9.7
1.86 ± 0.14 m²
1.89 ± 1.50 %
72.40 ± 18.9
45.50 ± 10.9
24.45 ± 7.0
3.1 ± 0.8
p
ns
ns
ns
ns
ns
ns
ns
ns
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Exclusion criteria were: emergency surgery, acute
myocardial infarction (AMI) less than three months
previously, unstable angina, uncontrolled diabetes mellitus,
inflammatory diseases, cardiac ejection fraction < 30%,
creatinine level > 2.0 mg/dL, total bilirubin level > 2.5 mg/
dL, use of acetylsalicylic acid, corticosteroids or any kind
of non-hormonal anti-inflammatory medication less than 7
days prior to surgery, Glasgow Coma Scale < 10, ileus or
recent bleeding from the upper digestive tract.
The following demographic information was collected
on the patients: gender, age, body surface area, surgical
logistic risk score (EuroSCORE) [6], duration of ECC,
duration of aortic clamping, duration of myocardial ischemia,
and number of coronary grafts received. Standard
techniques were used for anesthesia and ECC.
Methylprednisolone at the dose of 30 mg/kg was
administered shortly after induction of anesthesia in all
patients. In the group in which ultrafiltration was to be
carried out, a polyacrylonitrile (PAN) synthetic membrane
filter (650 SF 1.3 - Laboratórios B. Braun S.A., Rio de Janeiro,
Brazil) was installed in the recirculation line between the
venous reservoir and the oxygenator. The rate of
utrafiltration was controlled at 1000 mL/hr and done during
the entire period of ECC.
Patients received heparin prior to ECC using a dose of
400 IU/kg and additional doses were administered as
necessary to maintain the activated coagulation time (ACT)
> 500 seconds. ECC was initiated with a flow of 2.4 - 2.6 l/
min/m2, and mild systemic hypothermia (32-33oC) was
induced in all patients and monitored through a
nasopharyngeal sensor. Following aortic clamping, cardiac
arrest was achieved using antegrade warm blood
cardioplegia. Distal anastomoses were created the aortic
clamp was removed, and the proximal anastomoses in the
aorta were completed during the re-warming period. ECC
was terminated during rewarming when the nasopharyngeal
temperature reached 37oC, and heparin was neutralized using
protamine sulphate.
Parameters analyzed
The Sequential Organ Failure Assessment (SOFA) score
[7] used in this study evaluates six organs and systems
based on the following measures: the respiratory system
(the ratio of arterial oxygen tension to fractional inspired
oxygen concentration - PaO2/FiO2), the central nervous
system (Glasgow Coma Scale), the liver (bilirubin level),
coagulation (number of platelets), the kidneys
(concentration of creatinine) and the cardiovascular system
(level of hypotension). Calculation of the SOFA score was
made according to the parameters below and the final result
was the sum of the points obtained for each organ or system
evaluated:
1. PaO2/FiO2: above 401: 0 points; 400 - 301: 1 point;
300 - 201: 2 points; 200 - 101 with respiratory support: 3
points; below 100 with respiratory support: 4 points.
2. Platelets (x 103/mm3): above 150: 0 points; 149 - 101:
1 point; 100 - 51: 2 points, 50 - 21: 3 points; below 20: 4
points.
3. Bilirubin (mg/dL): below 1.2: 0 points; 1.2-1.9: 1 point;
2.0-5.9: 2 points; 6.0-11.9: 3 points; above 12: 4 points.
4. Hypotension: no hypotension: 0 points; mean
arterial pressure (MAP) < 70 mmHg: 1 point; dopamine < 5
ìg/kg/min or dobutamine (any dose): 2 points; dopamine 5
- 14 ìg/kg/min or noradrenalin d” 0.1 ìg/kg/min: 3 points;
dopamine > 15 ìg/kg/min or noradrenalin > 0.1 ìg/kg/min:
4 points.
5. Glasgow Coma Scale: 15: 0 points; 13-14: 1 point; 10-
12: 2 points; 6-9: 3 points; < 6: 4 points.
6. Creatinine: (mg/dL): below 1.2: 0 points; 1.2-1.9: 1
point; 2.0-3.4: 2 points; 3.5-4.9 or urinary volume 21 - 500
mL/day: 3 points; > 5.0 or urinary volume below 20 mL/day:
4 points.
Laboratory parameters
Serial samples of arterial blood were collected from a
radial artery, punctured to monitor mean arterial pressure.
Arterial blood was analyzed to measure cytokines,
complement, platelets, bilirubin and creatinine prior to
induction of anesthesia (T1), 5 minutes before the start of
ECC (T2), 30 minutes (T4), and 6 (T5), 12 (T6), 24 (T7), 36
(T8) and 48 (T9) hours after the end of ECC. Measurement
of plasma levels of cytokines (TNF-á, IL-6 and IL-8) was
carried out using an enzyme-linked immunosorbent assay
(ELISA; Duoset Kit, R&D Systems, Inc., Minneapolis, MN,
USA).  IL-1â was assessed using an ultra-sensitive kit
(sensitivity 0.1 pg/mL), (R&D Systems, Inc., Minneapolis,
MN, USA). C3a and C4a were measured by
immunonephelometry (BN Prospec, Dade Behring) in serum
samples and the results were expressed as g/L.  The normal
reference values applied for serum were C3a: 0.9 -1.8 g/L
and C4a: 0,1- 0,4 g/L.  Gasometry was performed using an
ABL3 apparatus (Radiometer, Copenhagen, Denmark). A
sample of the ultrafiltered fluid was collected (T3) to measure
the levels of TNF-á, IL-1â, IL-6, IL-8, C3a and C4a from the
patients whose serum had undergone ultrafiltration.
Creatinine and bilirubin were measured at T1, T6, T7, T8
and T9. Platelet count was carried out at all time-points
except T3.
Statistical analysis
The two groups were evaluated using parametric tests:
analysis of variance, Student’s t-test and chi-squared test
for unpaired samples. For the evaluation of interleukins
and activated complement, the Mann-Whitney test was
applied.  Differences were considered significant when
p<0.05. The GraphPad Prism software package, version 3.00
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for Windows (GraphPad Software, San Diego, California,
USA, www.graphpad.com) was used in the analysis.
RESULTS
The results obtained with serum measurements of C3a
and C4a, IL-1â, IL-6, IL-8 and TNF-á are shown in Figures
1 to 6.
C3a over time: Baseline values did not differ
significantly between the two groups. Values were slightly
decreased prior to extracorporeal circulation (ECC),
remained stable during ECC, and were lowest after ECC.  At
T5, T6 and T7 (6, 12 and 24 hours after ECC respectively),
C3a values were significantly higher in the group without
ultrafiltration than in the group with ultrafiltration.
Fig. 1 - C3a over time. Group 1 - no ultrafiltration; Group II - with
ultrafiltration. * statistically significant
Fig. 2 - C4a values over time.  Group 1 - no ultrafiltration; Group
II - with ultrafiltration. * statistically significant
Fig. 3 - Interleukin 1-â values over time.  Group 1 - no
ultrafiltration; Group II - with ultrafiltration. * statistically
significant
Fig. 4 - Interleukin 6 values over time. Group 1 - no ultrafiltration;
Group II - with ultrafiltration. * statistically significant
Fig.5 - Interleukin 8 values over time. Group 1 - no ultrafiltration;
Group II - with ultrafiltration. * statistically significant
Fig. 6 - TNF-á values over time. Group 1 - no ultrafiltration;
Group II - with ultrafiltration. * statistically significant
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C4a values over time: Baseline values did not differ
significantly between the two groups. At T5 and T6 (6 and
12 hours following the end of ECC, respectively), C4a values
were significantly higher in the group without ultrafiltration
than in the group with ultrafiltration. C4a values did not
differ between the two groups at any other time-points.
Interleukin 1-â values over time: Interleukin-1-â levels
did not vary significantly before or after extracorporeal
circulation (ECC). The group without ultrafiltration had
slightly higher values than the group with ultrafiltration,
but the difference was not statistically significant.
Interleukin 6 values over time: Baseline values did not
differ between the two groups. At T4 (30 minutes following
extracorporeal circulation [ECC]), interleukin-6 increased
markedly with respect to baseline but did not differ between
the two groups.  The levels gradually decreased, and at T7
and T8 (24 and 36 hours after ECC respectively) the group
with ultrafiltration had significantly higher values than the
group without ultrafiltration.
Interleukin 8 values over time: At baseline the IL-8
levels did not differ, but increased markedly in both groups
at T4, after extracorporeal circulation (ECC).  Note the
gradual decrease in levels after T5 (6 hours after ECC).  IL-
8 levels did not differ significantly between the two groups.
TNF-á values over time: At baseline TNF-á levels did
not differ- significantly between the two groups. Starting
at T5 (6 hrs after extracorporeal circulation), TNF-á
increased in the group with ultrafiltration and decreased in
the group without ultrafiltration; however, the groups did
not have any statistically significant differences.
With respect to the variables analyzed in the
ultrafiltered fluid, significant filtration was only achieved
in the case of TNF-á (34.540 ± 21.840 pg/mL). This value
was higher in the ultrafiltrate collected at T3 than in the
serum collected at T1 in both groups.  No statistically
significant difference was found in the SOFA scores at T1,
T6 and T9 (Table 2).
use of ultrafiltration in these cases is highly effective,
improving the hydro-electrolytic balance, reducing swelling
and balancing hemodynamics. It has been used principally
in pediatric surgery in low-weight children undergoing ECC,
when the volume of priming is generally greater than the
body volume. Ungerleider [8] reported that modified
ultrafiltration in pediatric ECC reduces total body fluid and
serum levels of inflammatory mediators, resulting in
elevation of hematocrit without transfusion and an
improvement in pulmonary compliance in the immediate
postoperative period.
The technique of ultrafiltration has been shown to be
effective in improving postoperative hemodynamics [8-10] and
restoring myocardial [1], cerebral [11], respiratory [4] and
hemostatic [9] function following pediatric cardiac surgery.
These benefits are principally attributed to the capacity of
ultrafiltration to remove excess free-water from plasma [9].
There are controversies regarding the efficacy of
ultrafiltration in removing inflammatory mediators (cytokines
and complements) and improving the inflammatory response
triggered by ECC [1] and postoperative morbidity in neonates
and children [9]. The conflicting results from the various
studies in the literature [3,12] are partially explained by the
different methods of ultrafiltration and the different types of
filters with various physical and functional properties. In
this study, we chose a synthetic membrane filter capable of
supporting high flow rates, with a porosity that allows the
passage of particles of up to 30 kDa. Nevertheless, the
transport of inflammatory mediators by convection does not
depend exclusively on their molecular weight.  Other physical
factors interfere with the passage of these solutes, making
efficacy based only on molecular size unpredictable. Other
variables that interfere with transport are: spacial
conformation of the molecule, electrical charge, hydrophilia
and hydrophobia, ligation to acute phase reactive proteins,
and ligation to receptors [13,14]. Current evidence suggests
that the most promising option for cytokine clearance is
through the mechanism of adsorption in certain types of
membrane (polyacrylonitrile, polymethylmethacrylate) during
ultrafiltration, along with convective transport of other
molecules that have not been detected in ultrafiltration [9].
Tetta et al. [9] suggest that some polymer derived membranes
behave as sponge layer, therefore, during the convection,
the force at the interior of the membrane expands its pores
and the area exposed for adsorption of bigger molecules
increases. We chose polyacrylonitrile filter because of its
largest available pores (30 kD x 20 kD polysulfone filter) which
allowed us to study the molecules in question. We didn’t
think of internal washing of the hemofilter for detection of
the cytokines retained by adsorption during the elaboration
of the study. That procedure could help us understand better
the filtering process that took place.
The diversity of the studied population was one of the
Table 2. SOFA score in the two groups.
Group I - no ultrafiltration, Group II - with ultrafiltration
Time
Group I
Group II
p-value
T1
0.525 ± 0.289
0.600 ± 0.250
0.8926
T6
1.220 ± 0.095
1.210 ± 0.196
0.9893
T9
1.050 ± 0.352
1.260 ± 0.193
0.8208
DISCUSSION
Ultrafiltration has been used frequently in ECC,
principally in patients with compromised renal and/or
cardiac function in whom volemic control is difficult. The
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reasons for difficulties in comparing the obtained data. In
this study, comparing gender, age, body surface, surgical
risk score (Euroscore), CEC time, aortic clamping time,
myocardial ischemic time and number of coronary artery
grafts received, there were no differences between the two
groups, as shown in Table 1.
The IL-1â and TNF-á stimulate the systemic liberation
of IL-6 e IL-8, increasing, in this way, the inflammatory
response [15]. The IL-8 is a protein of low molecular weight,
belongs to a family of cytokines. It is a potent quimiotaxic
agent and activator of neutrofils, capable of increasing the
inflammatory response through induction of liberation for
free radicals and proteolytic enzymes.
Circulating levels of TNF-á, IL-6, and IL-8 are not present
in normal healthy subjects [16]. Tumoral necrosis factor
alpha and IL-8 were present in pre-operatory period (T1) in
plasma of most of the subjects in our research. The TNF-á
has been detected previously in circulation of patients with
chronic heart failure, and we suggest that this finding reflect
the severity of the cases.
IL-6 is the key mediator in the acute phase response to
tissue injury or infection, inducing hepatic synthesis of acute-
phase proteins [17]. Elevated plasma levels of IL-6 occur
following both cardiac surgery with ECC [18] and non-cardiac
surgery [19].  In the present study IL-6 release was high in
both patient groups (with and without ultrafiltration), peaking
30 minutes after termination of ECC.  Higher measurements
were found in the ultrafiltration group at all time-points;
however, the difference was statistically significant only at
24 and 36 hours following the end of ECC.  This implies a
greater acute phase response and suggests a greater degree
of tissue damage with the use of ultrafiltration.
The role of neutrophil activation in lung and myocardial
injury following ECC has been well-documented [20]. This
led us to measure IL-8, a potent neutrophil chemotactic and
activating factor [21]. Unlike IL-6, there was no statistically
significant difference between the group with ultrafiltration
and the group without ultrafiltration.  A possible interpretation
for this disparity in the release of these two cytokines is that
IL-8 release occurs principally in situations of ischemic-
reperfusion injury [22], whereas IL-6 release reflects organ
response to any kind of acute insult.
Brasil et al [23] studied patients who underwent
myocardial revascularization with or without the use of ECC,
and detected the presence of TNF-á only in the group in
which ECC was used. In our study TNF-á had a different
pattern than that of other interleukins. In the group in which
ultrafiltration was not carried out, TNF- á levels were
relatively consistent over time. The levels of TNF-á
increased slightly, but insignificantly, following ECC, and
later decreased to slightly below the levels found in the
collected 12 hours after the end of ECC. In the group in
which ultrafiltration was carried out, there was a gradual
but statistically insignificant increase at all time-points and
measurements remained high for up to 36 hours following
ECC. When we analyzed the ultrafiltered fluid, we observed
significant filtration of only TNF-á (34.540 ± 21.840 pg/mL),
this value being higher than that in the first serum sample
(T1) in both groups (Group I, 14.42 ± 12.16 pg/mL and Group
II 13.59 ± 1.98 pg/mL).  However, serum levels of TNF-á
were not significantly different between the two groups.
These findings suggest that although a great quantity of
this mediator was filtered by the ultrafiltrator membrane,
this procedure seems to have a simultaneous stimulating
effect on the production of this cytokine.
Activation of the complement cascade occurs during
ECC, predominantly by the alternative route [17]. The longer
the duration of ECC, the greater the activation of this
system, as expressed by the plasma concentration of C3,
C3a and C4 [24]. Additional activation of the complement
cascade by the heparin-protamine complex led to an increase
in the levels of C3a and C4a following protamine infusion.
Contrary to findings in the literature, in the present study
C3a and C4a concentrations were lower than control values.
C3a levels were significantly different between the two
groups at 6, 12 and 24 hours after ECC, and C4a levels were
significantly different at 6 and 12 hours after ECC, with
higher values in the group without ultrafiltration.
Patients who develop SIRS after ECC suffer changes in
organ function and in 1-2% of all cases this is related to
multiple organ dysfunction syndrome [3]. No statistically
significant differences were found in the SOFA scores
between groups.
The SOFA score was used because it is currently
considered one of the best methods for monitoring organ
dysfunction, since it monitors and grades the function of 6
systems (with points ranging from 1 to 4 in accordance
with the degree of dysfunction) rather than signs and
symptoms. In this way the SOFA score differs from the
APACHE score.
In this work all patients have received 30 mg/kg of
methilprednisolone, it is standard to perform bypass at our
institution. The corticosteroid administration has been
effective action on minimize systemic inflammatory
response during and after bypass [25,26].
In the late 1970s and early 1980s, some papers has
showed better outcome with methilprednisolone
administration in low cardiac output syndrome after bypass
with cardiac index increase, coronary blood flow
improvement, and lower periphery vascular resistance
[27,28]. Fey et al. [29] have showed protective effect by
corticosteroid administration with less myocardium
depression after ischemia and reperfusion. The
corticosteroids have properties on lysossomal stabilization
membrane, as consequence less cellular death and improve
on viable myocardial cells.
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